News & Updates
Filter by Specialty:
Rise in late-stage cervical cancer in SG linked to suboptimal screening uptake
Local researchers note a rising trend of late-stage cervical cancer in Singapore, a pattern that they say is likely to be an effect of a less than optimal uptake of screening for the disease.
Rise in late-stage cervical cancer in SG linked to suboptimal screening uptake
22 Aug 2022
Patient decision aid helps in decision-making process when selecting regimen for CRC
A newly developed patient decision aid (PDA) aids in the shared decision-making in choosing first-line targeted therapy for metastatic colorectal cancer (CRC), reports a study in Taiwan.
Patient decision aid helps in decision-making process when selecting regimen for CRC
22 Aug 2022
Is 5-year interval sufficient for prostate cancer screening in older men?
Diagnosis, progression, or death due to prostate cancer occur at approximately a decade to 15 years following an initial assessment of prostate-specific antigen (PSA) levels in older men, according to a study presented at EAU 2022.
Is 5-year interval sufficient for prostate cancer screening in older men?
18 Aug 2022
Local failure tied to survival in intermediate-risk PCa after definitive radiotherapy
In men with intermediate- or high-risk prostate cancer (PCa), local failure after definitive radiation therapy (RT) is indicative of survival outcomes, according to a recent study.
Local failure tied to survival in intermediate-risk PCa after definitive radiotherapy
18 Aug 2022
Survival benefit with postchemoradiation immunotherapy affirmed
Starting immunotherapy after chemotherapy and radiation for unresectable stage III nonsmall cell lung cancer (NSCLC) prolongs overall survival, regardless of patient age, health, and socioeconomic status, according to a large US study.